KIT and systemic mastocytosis: The initial SM diagnosis was considered based on 3 minor criteria listed (> 25% atypical bone marrow MCs, detection of KIT mutation, and serum tryptase persistently > 20 ng/mL), despite having another evolving small myeloid clone and mild bone marrow dysplasia.